AI has reached a turning point in biotech. Real-world scientific agents are beginning to automate the repetitive tasks that slow down research, and transform how we think about extracting insights from scientific data. In this webinar on… Read More
Quantum company IonQ has partnered with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutics using hybrid quantum and quantum-AI technologies. The collaboration will initially focus on areas including bioprocess optimisation, disease-modelling workflows, and quantum-enhanced simulation to support the design and manufacturing of advanced therapies. By bringing together CCRM’s expertise in… Read More
This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More
Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow challenges, from culture variability to labour-intensive handling. In this webinar, hosted by DDW and supported by Galatek, we will explore the evolving landscape of organoid research,… Read More
AI has reached a turning point in biotech. Real-world scientific agents are beginning to automate the repetitive tasks that slow down research, and transform how we think about extracting insights from scientific data. In this webinar on… Read More
AI has reached a turning point in biotech. Real-world scientific agents are beginning to automate the repetitive tasks that slow down research, and transform how we think about extracting insights from scientific data. In this webinar on… Read More
AI has reached a turning point in biotech. Real-world scientific agents are beginning to automate the repetitive tasks that slow down research, and transform how we think about extracting insights from scientific data. In this webinar on… Read More
Health technology company myTomorrows has secured $29 million in funding to develop its AI-driven global platform, aiming to bring patients access to innovative therapies. The company aims to develop a platform to bridge the gap between scientific advancement and patient access to pre-approval treatments. This includes drug candidates undergoing clinical… Read More
Rajesh Kumar, Senior Director of Structural Biology at Schrodinger, shares with Diana Turner how advanced computational models are supercharging modern drug discovery and the impact they could have in the future. DT: Can you tell us a bit more about Schrödinger and what you do? RK: Schrödinger’s (SDGR) core… Read More
Drug discovery company Insilico Medicine has entered a research collaboration with pharmaceutical giant Eli Lilly to advance AI-driven drug discovery. Insilico will use its validated Pharma.AI platform to generate, design, and optimise candidate compounds against targets defined under the agreement. The company is eligible to receive over $100 million including… Read More
DDW Editor Reece Armstrong speaks to Tyrone Lam, Chief Business Officer (CBO) at GATC Health, about how multiomics and AI can advance drug discovery in areas such as opioid use disorder (OUD). RA: What are the current challenges of traditional drug development processes? TL: Traditional drug development is often… Read More
The global outsourcing market is set to grow the fastest in China and the US but India has cooled its interest, analysis by Biobeat finds. Published ahead of CPHI Frankfurt, the world’s largest CDMO conference, the analysis reveals the market has demonstrated resilience, with higher growth ahead predicted for mAbs,… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, Galapagos announced plans to shelve its cell therapy business and hundreds of… Read More
Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. This webinar, hosted by DDW and supported by Danaher Life Sciences, explores how advanced platforms such as Genedata Profiler… Read More
News round-up for 20 – 24 October by Bruno Quinney, Content Team at DDW. This week’s leading story comes from biotech, with Galapagos announcing plans to shelve its cell therapy business and hundreds of employees set to lose theirjobs. Elsewhere, pharma firms are offering discounts to US… Read More
Genomics company Integrated DNA Technologies (IDT) has announced a strategic partnership with AI-first protein design Profluent Bio to design and optimise next-generation enzymes. The collaboration will bring together Profluent’s generative AI platform with IDT’s expertise in enzymology and genomics, with the aim of exploring new paths for developing novel enzyme… Read More
